Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Nebraska Oncology Society
E

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy of New RET Inhibitors? Should We Use Them 1L or 2L?

By Nebraska Oncology Society FEATURING Eric Sherman
By Nebraska Oncology Society FEATURING Eric Sherman
25 views
January 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
Head and Neck
08:09

ESMO 2023 Insights: "AIM-HN Study Evaluating Tipifarnib in mHRAS, Re…

Insights from 2023 ESMO Annual Meeting

A. Ho

115 views
18:07

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

1.8K views
22:27

NOS ASCO® 2023 Review: Head & Neck Cancer De-Escalation

Nebraska Oncology Society

E. Sherman

237 views
47:18

ASCO 2022 Review of Head & Neck Cancer Updates

Nebraska Oncology Society

E. Sherman

538 views
09:41

ASCO 2020 Review of Transoral Robotic Surgery for OPC : Is 2-yr PFS …

Nebraska Oncology Society

E. Sherman

13 views
09:24

2020 ASCO LA-HNSCC Trials Review: What Is the Efficacy of Weekly CDD…

Nebraska Oncology Society

E. Sherman

13 views
11:38

ASCO 2020 Update on DO-IMRT & HNC Metastatic: Does Change in IMRT Le…

Nebraska Oncology Society

E. Sherman

20 views
04:56

2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

15 views
08:09

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

25 views